CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study

Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection

NCT07146100 ·Status: RECRUITING

Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg

NCT01817725 ·Status: COMPLETED ·Phase: PHASE1

Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

NCT01356901 ·Status: COMPLETED

Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B

NCT03491553 ·Status: COMPLETED ·Phase: PHASE2

Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

NCT00158717 ·Status: COMPLETED

Optimization of Antiviral Therapy of Chronic HBV Infection

NCT01623778 ·Status: COMPLETED

An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection

NCT03692897 ·Status: TERMINATED

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B

NCT05828745 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of VTP-300 in Chronic Hepatitis B Infection

NCT05343481 ·Status: COMPLETED ·Phase: PHASE2

Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients

NCT02581033 ·Status: UNKNOWN ·Phase: NA

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

NCT00722332 ·Status: COMPLETED ·Phase: PHASE4

A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B

NCT07200193 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Towards a Functional Cure for HBV - The COMMIT Cohort Study

NCT03645044 ·Status: ACTIVE_NOT_RECRUITING

The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B

NCT02965859 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment

NCT03615066 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection

NCT04749368 ·Status: COMPLETED ·Phase: PHASE2

A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults

NCT07059403 ·Status: RECRUITING ·Phase: PHASE1

A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection

NCT06159062 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

NCT01671787 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B

NCT03625102 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

NCT00537537 ·Status: COMPLETED ·Phase: PHASE4

A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

NCT04225715 ·Status: COMPLETED ·Phase: PHASE2

Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial

NCT00362674 ·Status: COMPLETED

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

NCT05630807 ·Status: COMPLETED ·Phase: PHASE3

First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection

NCT04297917 ·Status: COMPLETED ·Phase: PHASE1